EUVIMEDEUVIMED entdecken
Fallbericht

ACOX1 gain‐of‐function variation in a 10‐years‐old patient responsive to immunomodulating therapy

Corinna Filippi iD, Sara Brunetti, Massimo Plumari, Enza Maria Valente, Patrizia Accorsi, Elisa Maria Fazzi

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63796 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Corinna Filippi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. Hauptthemen laut MEDLINE: Gain of Function Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A heterozygous gain‐of‐function variant in the acyl‐CoA oxidase 1 ( ACOX1 ) gene, c.710A>G (p.Asn237Ser), is known to cause Mitchell syndrome, a very rare progressive disorder characterized by episodic demyelination, sensory polyneuropathy, and hearing loss. Only eight patients have been described so far. A single patient has been treated with intravenous immunoglobulin administration, indicating clinical improvement. In this study, we describe a 10‐year‐old girl carrying the identical mutation, who presented with progressive sensorineural deafness, visual abnormalities, skin ichthyosis, and gait ataxia from infantile age with progressive worsening and loss of walking ability by the age of 10 years. Antioxidant therapies and monthly intravenous immunoglobulin infusions showed excellent clinical results: after 1 year of treatment, the child is now able to walk, run, and jump. We emphasize the importance of early genetic diagnosis since an effective treatment is available for this rare condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gain of Function MutationChildFemaleHumansDemyelinating DiseasesHearing Loss, SensorineuralImmunoglobulins, IntravenousImmunomodulationPhenotypeAcyl-CoA Oxidase

Stichwörter der Autor:innen

Mitchell syndromeacyl‐CoA oxidase 1ataxianeurodegenerative encephalomyelopathyprogressive polyneuropathysensorineural deafness

Substanzen

Immunoglobulins, IntravenousACOX1 protein, humanAcyl-CoA Oxidase

Autor:innen und Institutionen

  • Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Unit of Child Neurology and Psychiatry, ASST Spedali Civili of Brescia, Brescia, Italy.
  • Neurogenetics Research Center, IRCCS Mondino Foundation, Pavia, Italy.
  • Department of Molecular Medicine, University of Pavia, Pavia, Italy.

ORCID-Profile: Corinna Filippi

Zitieren

APA

Filippi, C., Brunetti, S., Plumari, M., Valente, E. M., Accorsi, P., & Fazzi, E. M. (2024). ACOX1 gain‐of‐function variation in a 10‐years‐old patient responsive to immunomodulating therapy. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63796

Vancouver

Filippi C, Brunetti S, Plumari M, Valente EM, Accorsi P, Fazzi EM. ACOX1 gain‐of‐function variation in a 10‐years‐old patient responsive to immunomodulating therapy. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63796

BibTeX
@article{Filippi2024,
  author = {Filippi, Corinna and Brunetti, Sara and Plumari, Massimo and Valente, Enza Maria and Accorsi, Patrizia and Fazzi, Elisa Maria},
  title = {ACOX1 gain‐of‐function variation in a 10‐years‐old patient responsive to immunomodulating therapy},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63796}
}
Kostenlos starten →